Company Overview

FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with primary applications in the area of cardiology. It develops positron emission tomography imaging agents for the detection and assessment of acute and chronic forms of coronary artery disease (CAD). The company?s clinical-stage molecular imaging pharmaceutical product candidates include BFPET, which is in Phase I trial used for the detection of ischemic and infarcted tissue within the myocardium in patients with suspected or proven chronic CAD; and CardioPET that is in Phase II development stage for the assessment of myocardial m...

read more


To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 500 Boylston Street, Suite 1600, Boston, MA 02116, United States
Mailing Address: -
Phone: 617-456-0366
Fax: 617-482-3337
Website: http//www.fluoropharma.com

Company Details:

Symbol: FPMI
SIC: -
State location: NJ
Sector: -
State of Inc: NV
Employees: 4
Type: -

Key executives:

Name Age Position

Type the characters that you see in the box (5 characters).